EU IVDR CE Certificate Under Article 51: Validity, Renewal and Conditions

1. Key takeaways

IVDR certificates are valid for a maximum of 5 years (Article 51(2)): a certificate is valid for the period indicated on it, which shall not exceed five years; at the request of the manufacturer, it may be renewed for periods not exceeding five years each, based on a re-assessment in accordance with the applicable conformity assessment procedure; and a supplementary certificate remains valid for the period of validity of the certificate it supplements. The minimum content of certificates follows Annex XII, and the language of issuance is determined by the Member State in which the notified body is established (Article 51(1)).

Certificates are therefore not static pieces of paper but managed regulatory objects. Their period of validity drives the renewal calendar; their content can carry conditions such as restrictions of intended purpose or obligations to conduct post-market performance follow-up studies; and their status is published in the electronic system of Article 52, meaning that suspensions, withdrawals and restrictions are visible to the market. A manufacturer that maintains a certificate ledger, plans renewals backwards and integrates certificate conditions into its post-market surveillance system turns Article 51 from a source of surprises into a routine compliance cycle.

2. Legal basis

The table below lists the primary legal sources on certificates under Article 51.

3. Expert insights

Insight 1: five years is a ceiling, not a default.

The wording of Article 51(2) is that certificates are valid for the period they indicate, which shall not exceed five years. A notified body may issue a shorter period, and the practical estimate is that first certificates are often issued for a shorter duration to observe how the system performs. Treating five years as the default cycle in capacity planning therefore misaligns renewal windows. The certificate ledger should record the period indicated on each certificate, not the regulatory maximum, and all downstream planning should start from the recorded date.

Insight 2: renewal is a re-assessment, with an intensity close to the initial assessment.

Article 51(2) requires renewal to be based on a re-assessment in accordance with the applicable conformity assessment procedures. (EU) 2026/977, applicable from 2027-02-25, sets a 90-day limit for re-certification assessments and restricts notified bodies from repeatedly requesting information already confirmed as unchanged. A renewal plan should start well in advance; the practical estimate is twelve months of lead time. Starting late compresses the re-assessment into the final months of validity, and a lapse in validity interrupts the legal basis for placing devices on the market.

Insight 3: certificates can be restricted, suspended or withdrawn, and the status is public.

Under Article 51(4), where a notified body finds that a manufacturer no longer meets the requirements of the Regulation, it shall suspend or withdraw the certificate or impose restrictions, proportionate to the non-conformity, unless the manufacturer restores compliance through corrective action within an appropriate period set by the body, and it shall give reasons for its decision. Under Article 51(5), the notified body enters information on issuance, amendment, supplementation, suspension, reinstatement, withdrawal, refusal and restriction of certificates into the electronic system of Article 52, and that information shall be publicly available, applicable since 2023-11-27. Certificate status is thus market-visible, and a suspension is not a private matter between manufacturer and body.

Insight 4: certificates can carry PMPF obligations.

Article 51(3) allows the notified body to restrict the intended purpose of a device to specific patient or user groups, or to require the manufacturer to conduct specific post-market performance follow-up (PMPF) studies in accordance with Part B of Annex XIII. Such conditions are part of the certificate content and must flow into the internal post-market surveillance plan and budget. Conditions imposed on the certificate but not resourced internally are a recurring finding in later surveillance, so the integration should happen as soon as the certificate is issued.

4. Practical recommendations

The following actions make certificate management a controlled process.

1. Maintain a certificate ledger: certificate number, issuing body (four-digit number), date of issue, indicated period of validity, scope and any additional conditions.
2. Plan renewals backwards from the indicated period of validity, allowing time for the re-assessment and corrective work; the practical estimate is twelve months of lead time.
3. Integrate PMPF conditions under Article 51(3) into the post-market surveillance plan and budget.
4. Where a certificate is suspended, withdrawn or restricted, seek the corrective period under Article 51(4) and assess in parallel the notification duties towards downstream customers.
5. From 2027-02-25, manage change and re-certification against the time limits of (EU) 2026/977 (change assessment 30 days, supplementary assessment 90 days, supplementary certificate 20 days).

5. Verification checklist

Confirm the following points on certificate management.

• □ The indicated period of validity of each certificate has been recorded and confirmed not to exceed 5 years (Article 51(2))
• □ A backwards renewal plan is in place (practical estimate: twelve months of lead time)
• □ The minimum content of the certificate has been checked against Annex XII
• □ Additional conditions (PMPF, restrictions of purpose) have been integrated into the post-market surveillance plan (Article 51(3))
• □ The public status of certificate information in EUDAMED or the Article 52 electronic system has been reviewed
• □ Change and re-certification processes have been aligned with (EU) 2026/977 (2027-02-25)

Regulatory information verified as of October 29, 2026.

GRZAN supports IVD manufacturers in the EU market with CE certification pathway and classification strategy under Regulation (EU) 2017/746. For certificate management we help you build certificate ledgers, plan renewals against Article 51 and the (EU) 2026/977 timelines, integrate PMPF conditions into post-market surveillance and respond to suspension or restriction situations. Contact us at info@grzanglobal.com to discuss your EU IVDR programme.